News

Femtech Investment Round-up: December 2023

What’s New in Femtech This Week? (Jan 4, 2024)

Manina Medtech Secures €1.75M for Device Promising Higher IVF Success Rates

29 UK Medical Research Organizations Pledge Support for Sex and Gender Research Policy

Maven Clinic Study Highlights Effectiveness of Virtual Doula Care in Maternal Health

Fertility Tech Company TMRW Life Sciences Expands to the UK

Femtech in 2023: A Year in Headlines

What’s New in Femtech This Week? (Dec 21, 2023)

Introducing Femtech Bot: The New AI Companion on Your Femtech Journey

Organon Expands European Portfolio with Lilly Migraine Medicines

Biorithm Secures $3.5M in Series A Funding for Its Obstetric Remote Monitoring Solution

2023? It’s a Wrap!

Inside FemTech Fund III: How Portfolia Founder Trish Costello Leads the Charge in Women’s Health Investing

Kegg Unveils Study Showing Potential for Hormone-Free Birth Control Through Cervical Fluid Tracking

Clue Partners with Universities to Research and Address Female Health Diagnosis Gap

Astellas’ VEOZAH Wins EC Approval to Treat Menopause-Related Hot Flashes

Why Amazon CTO Werner Vogels Thinks Femtech Will Take Off in 2024

ASPIVIX Receives CE Mark for Carevix, Its Device to Lower IUD Procedural Pain

Lunit Targets US Market with $193M Acquisition of AI-Enabled Breast Cancer Detection Platform Volpara

YourChoice Therapeutics Begins Landmark Trial for Hormone-Free Male Birth Control Pill

New Study Funded by $3M Government Grant Explores Connection Between Genomics and IVF Outcomes

Sustainable Femcare Brand Yoni Raises €2.3M for European Expansion

What’s New in Femtech This Week? (Dec 14, 2023)

Aditxt Enters Women’s Health Market with $100M Evofem Acquisition